1630 results for Leukemia
Refine Your Search
The Leukemia & Lymphoma Society's Response to the Israel-Hamas War
The following message was sent to all LLS employees on October 11, 2023: Dear LLS Community, As an organization, The Leukemia & Lymphoma Society (LL…
News Release
Improving CAR T-cell Therapy Efficacy in Acute Lymphoblastic Leukemia by Optimizing Design and Placement
Pediatric acute lymphoblastic leukemia (ALL) that is resistant to standard therapy is a challenge that has been partially overcome by T-cell therapy, …
The Leukemia & Lymphoma Society and Blood Cancer UK Team Up to Award $4.25M for Research into Ways to Prevent Leukemia
RYE BROOK, N.Y., February 5, 2024 — The Leukemia & Lymphoma Society (LLS) and Blood Cancer UK announced today a five-year, $4.25 million grant to laun…
News Release
Count on LLS this Blood Cancer Awareness Month
September is Blood Cancer Awareness Month, and The Leukemia & Lymphoma Society is leading the way in blood cancer support, research, and advocacy.
The Leukemia & Lymphoma Society Joins CancerX Inaugural Project
The Leukemia & Lymphoma Society (LLS) has joined on as a proud partner of CancerX’s inaugural project, “Advancing Digital Innovation to Improve Equit…
News Release
The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer
The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer.
News Release
Dynamic prediction of outcomes in acute myeloid leukemia using machine learning that integrates genotype and phenotype
Acute myeloid leukemia is life-threatening and heterogeneous, and although classification models help guide treatment, they do not use detailed phenot…
Harnessing METTL3 inhibition in acute megakaryoblastic leukemia driven by the t(1;22) fusion involving a member of the m6A writer complex
I want to understand how the t(1;22) translocation that involves a member of the m6A writer complex drives acute megakaryoblastic leukemia (AMKL). To …
FDA Expands Use of Leukemia Treatment to Include Children
LLS supported the very first antibody-drug conjugate gemtuzumab ozogamicin, which targets CD33, and was approved in 2000 to treat acute myeloid leukem…
News Release
Treating Myelodysplastic Syndromes Transformation to Acute Myeloid Leukemia
This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with hema…
Education Resources
Treating Myelodysplastic Syndromes Transformation to Acute Myeloid Leukemia
This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with hema…
Education Resources
Advancing the therapeutic landscape for Chronic Myelomonocytic Leukemia (CMML)
CMML is a universally lethal blood cancer characterized by increased monocytes (a type of white blood cell) in the peripheral blood and abnormal appea…
Niclosamide for the treatment of relapsed pediatric acute myeloid leukemia
Niclosamide is an FDA approved anti-parasitic drug that is well tolerated in adults and children. AML cells are sensitive to niclosamide, act synergis…
Charting the surfaceome to eliminate hairy cell leukemia (HCL)
To optimize treatment of HCL, we dissect the tumors` surface proteome to understand a) surface mediated signals and b) the dependence on BRAFV600E act…
The Impact of Minimal Residual Disease in Acute Lymphoblastic Leukemia
[Click here to enlarge.] Presentation Click Here Topics Covered We invite you to learn more about: …
The Leukemia & Lymphoma Society Honors Dr. Sherie Morrison
On Wednesday, November 7, The Leukemia & Lymphoma Society California Southland Chapter held a dinner to honor Dr. Sherie Morrison, a preeminent resear…
Blood And Marrow Transplantation For Children With Acute Lymphoblastic Leukemia
Presentation Click Here Topics Covered We invite you to learn more about: The indication for hematopoietic cell transplant (HCT) in acute lym…
Understanding Your Diagnosis: Acute Myeloid Leukemia (AML)
Topics Covered We invite you to learn more about: New treatments for AML Side-effects management The importance of clinical trials for AML …
Chronic myeloid leukemia (CML) in children and young adults
Most cases of CML occur in adults. From 2015-2019, less than 2 percent of all cases of CML occurred in children, adolescents, and young adults younger…
Blood Cancer
Chronic Myeloid Leukemia: Patient Experience Not Well Understood
Chronic Myeloid Leukemia: Patient Experience Not Well Understood FOR IMMEDIATE RELEASE Linda House 317-997-0561 [email protected] Andre…
NRG Announces New Partnership with The Leukemia & Lymphoma Society
Los Angeles, CA - (September 13, 2019) - NRG announced The Leukemia & Lymphoma Society (LLS), the global leader in the fight to end blood cancer, as t…